Fidelity Investments’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Fidelity Investments’s Portfolio PARN Stock Details PARN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-20,140	Closed	-$14K	–	2790
2016 Q4	$14K	Sell	20,140 -795,911	-98%	-$948K	﹤0.01%	2645
2016 Q3	$1.18M	Hold	816,051	–	–	﹤0.01%	2436
2016 Q2	$1.33M	Hold	816,051	–	–	﹤0.01%	2443
2016 Q1	$1.82M	Hold	816,051	–	–	﹤0.01%	2407
2015 Q4	$3.16M	Hold	816,051	–	–	﹤0.01%	2317
2015 Q3	$2.81M	Hold	816,051	–	–	﹤0.01%	2338
2015 Q2	$4.04M	Hold	816,051	–	–	﹤0.01%	2298
2015 Q1	$4.01M	Hold	816,051	–	–	﹤0.01%	2286
2014 Q4	$3.38M	Hold	816,051	–	–	﹤0.01%	2333
2014 Q3	$4.69M	Buy	+816,051	New	+$4.92M	﹤0.01%	2248

Other funds holding PARN

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Fidelity Investments's PARN Position: Q1 2017 in Review

Fidelity Investments sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 20,140 shares — an estimated $14K sold.

Fidelity Investments first reported a position in PARN in Q3 2014 and held it in 10 quarters. The position peaked at $4.69M in Q3 2014. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

Fidelity Investments reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
Fidelity Investments sold 20,140 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017, an estimated $14K.
Fidelity Investments first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q3 2014 and held it in 10 quarters.
Fidelity Investments's Parnell Pharmaceuticals Holdings Ltd position peaked at $4.69M in Q3 2014.
2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Fidelity Investments's 13F filing for Q1 2017, filed 11 May 2017.